Events

Vivet Therapeutics is excited to announce two poster presentations at ESGCT 2025 in Sevilla, showcasing innovative advances in liver-directed gene therapy. Catch us on Thursday,

Vivet Therapeutics is delighted to announce its participation in the European Society of Gene & Cell Therapy (ESGCT) Annual Congress, taking place in Sevilla, on

 📢 @Vivet Therapeutics is heading west for The Liver Meeting in sunny ☀ San Diego, California! ⛱  Listen in as #Vivet’s Co-founder & Chief Scientific

Join our Co-Founder & Chief Executive Officer, @Jean-Philippe Combal, and @Susan Coles, General Counsel and Head of Finance at #BIOEurope2024 in Stockholm, Sweden from 4-6

📣#VivetTherapeutics is headed to the land down under!📣 Join our Co-Founder and CSO, Dr @Gloria Gonzalez-Aseguinolaza at the Australasian Gene and Cell Therapy Society (#ASGCT)

Connect with Co-Founder & CEO, @Jean-Philippe Combal & Director of Regulatory Affairs & Quality Assurance, @Annelise Brossel at the inaugural Cell & Gene Therapy Regulatory

With over 25 years of expertise in #drugdevelopment, our Head of Clinical Operations & Patient Advocacy Representative, @Sonia Valero, will join industry leaders on a

Don’t miss the opportunity to meet the @Vivet Therapeutics leadership team who will be participating in a jam-packed schedule at the event. 👂Listen in as

🎉 25th Anniversary of the Spanish Society of Gene🧬& Cell🦠Therapy! 🎉 Join our Co-Founder & Chief Scientific Officer, Dr @Gloria Gonzalez-Aseguinolaza in celebrating this special

🤝Connect with @Sonia Valero, Head of Clinical Ops & Patient Advocacy Representative at @Vivet Therapeutics and US Patient Advocacy Consultant @Lori Mckenna, at the upcoming